Projected Price to Earnings: NeuroBo (NRBO)

Graphic logo of NeuroBo Pharma (NRBO)

Patent protection for anti-obesity and neuropathy treatments creates a robust market barrier for NeuroBo Pharmaceuticals (NRBO). The company's forward P/E ratio visualizes this potential, with the value 0.00 describing the current level. Success is based on MASH drug trials conducted in partnership with Dong-A ST, as well as the recruitment of top researchers working in a high-tech environment with a competitive benefits package.

Future Price to Earnings Multiple: NeuroBo Pharmaceuticals, Inc. (NRBO) for 07/04/2022 - 12/07/2024

Analytical breakdowns for neurobopharma.com (NRBO)

- company stock exchange capitalization indicators:
Analysis of all company metrics:NeuroBo NRBO
Brand item of NeuroBo Pharmaceuticals

NeuroBo Pharmaceuticals' development of obesity and liver disease drugs makes its share price dependent on expected future earnings. This consensus P/E forecast compares the company's current market capitalization with analyst net income projections, where low values minimize loss risks and high values reflect market optimism regarding the success of clinical trials.

Direct competitors

Forward P/E Multiple BIIB|NBIX - Projected Price to Earnings Ratio|Forward P/E Multiple RGC (Regencell Bioscience Ltd)|Market Cap to Projected Earnings axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Future Price to Earnings|Supernus Corp - Future Price to Earnings Multiple|Projected Price to Earnings CPRX|Denali Therapeutics Inc. (DNLI) - Market Cap to Projected Earnings|Projected Price to Earnings HRMY (Harmony Corp)|BHVN - Projected Price to Earnings Ratio|Future Price to Earnings Amylyx Pharmaceuticals, Inc. AMLX|Future Price to Earnings Multiple TRVI|PRAX - Future Price to Earnings|Market Cap to Projected Earnings Anavex Life Sciences AVXL|CBLL: Forward P/E Multiple|Projected Price to Earnings Prothena Corporation PLC|ALEC (alector.com) - Forward P/E Multiple|Projected Price to Earnings Annexon, Inc. (ANNX)|Future Price to Earnings Omeros Corporation (OMER)|Neurogene Inc. - Price to Future Earnings Ratio|acimmune.com - Projected Price to Earnings|Forward P/E Multiple Voyager Therapeutics Inc VYGR|NMRA - Future Price to Earnings|Forward Price to Earnings Multiple Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Future Price to Earnings|Price to Future Earnings Ratio ACOG|Future Price to Earnings Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Price to Expected Earnings Ratio|Projected Price to Earnings SAVA (Cassava)|Market Cap to Projected Earnings Assertio Therapeutics|Coya Therapeutics, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Forward P/E Multiple|Acumen Pharmaceuticals, Inc. (ABOS) - Projected Price to Earnings|CRVO (CervoMed, Inc.) - Projected Price to Earnings|Projected Price to Earnings Alterity Therapeutics Ltd|Future Price to Earnings Clene Inc.|PepGen Inc. - Price to Expected Earnings Ratio|Projected Price to Earnings JUNS (Jupiter Neurosciences Inc)|Future Price to Earnings RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Projected Price to Earnings|Market Cap to Projected Earnings Grace Tx (GRCE)|fireflyneuro.com - Forward P/E Multiple|Klotho Neurosciences (KLTO) - Projected Price to Earnings|NeuroSense Therapeutics, Ltd. (NRSN) - Future Price to Earnings|Price to Expected Earnings Ratio RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - Forward P/E Multiple|NRXS: Future Price to Earnings Multiple|Forward P/E Multiple HSDT|Forward P/E Multiple Passage Bio Inc. (PASG)|Future Price to Earnings bionomics.com.au NEUP|Forward P/E Multiple Minerva Neurosciences Inc NERV|ATHA: Projected Price to Earnings|ADXN (Addex Therapeutics, Ltd.) - Price to Future Earnings Ratio|Alzamend Neuro Inc. (ALZN) - Future Price to Earnings|Cyclerion - Future Price to Earnings Multiple|Future Price to Earnings protagenic.com|Pasithea Therapeutics - Price to Expected Earnings Ratio|Projected Price to Earnings CRGT (Cortigent, Inc.)|Avenue Therapeutics - Price to Future Earnings Ratio|Future Price to Earnings Brainstorm Cell BCLI|Forward P/E Multiple caratherapeutics.com CARA|Chromocell Therapeutics Corp. - Forward P/E Multiple|eliemtx.com - Market Cap to Future Earnings Ratio|Intra-Cellular Therapies (ITCI) - Future Price to Earnings|LBPH (Longboard) - Future Price to Earnings|MRNS (marinuspharma.com) - Forward P/E Multiple|Projected Price to Earnings Ratio NKGen Biotech NKGN|Projected Price to Earnings SAGE (Sage Therapeutics, Inc.)|Market Cap to Projected Earnings Neurotrope|Future Price to Earnings Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Projected Price to Earnings Ratio|WENA: Projected Price to Earnings|Future Price to Earnings Multiple CERE (Cerevel Therapeutics)